Corbus Pharmaceuticals' Shares Triple Following Results From Phase 1 Cancer Study - MarketWatch
marketwatch.comSubmitted by marketwatch5869 in business
By Adam L. Cataldo Shares of Corbus Pharmaceuticals Holdings more than tripled on Friday after it reported positive results from its first-in-human study of...